Cereno Scientific Investor Relations Material
Latest events
Study Update
Cereno Scientific
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cereno Scientific
Access all reports
Cereno Scientific is a biotechnology company developing epigenetic therapies for cardiovascular and rare diseases. The company focuses on compounds that modulate endogenous defense mechanisms, with applications in thrombosis and inflammation. It operates in preclinical and clinical research stages. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the STO.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
CRNO
Country
🇸🇪 Sweden